Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A S, Bura"'
Autor:
Kanwardeep S. Bura, Caleb Lord, Stephanie Marshall, Allison McDaniel, Gwyn Thomas, Manya Warrier, Jun Zhang, Matthew A. Davis, Janet K. Sawyer, Ramesh Shah, Martha D. Wilson, Arne Dikkers, Uwe J.F. Tietge, Xavier Collet, Lawrence L. Rudel, Ryan E. Temel, J.Mark Brown
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 6, Pp 1567-1577 (2013)
Reverse cholesterol transport (RCT) can proceed through the classic hepatobiliary route or through the nonbiliary transintestinal cholesterol efflux (TICE) pathway. Scavenger receptor class B type I (SR-BI) plays a critical role in the classic hepato
Externí odkaz:
https://doaj.org/article/3a20126870d74e40957cadd9cffdc795
Autor:
Martha D. Wilson, Allison L. McDaniel, Xavier Collet, Ramesh Shah, Kanwardeep S. Bura, Caleb C. Lord, Janet K. Sawyer, Uwe J. F. Tietge, Arne Dikkers, J. Mark Brown, Ryan E. Temel, Matthew A. Davis, Jun Zhang, Gwyn Thomas, Lawrence L. Rudel, Stephanie M. Marshall, Manya Warrier
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 6, Pp 1567-1577 (2013)
Journal of Lipid Research, 54(6), 1567-1577. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Journal of Lipid Research, 54(6), 1567-1577. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Reverse cholesterol transport (RCT) can proceed through the classic hepatobiliary route or through the non-biliary transintestinal cholesterol efflux (TICE) pathway. Scavenger receptor class B type I (SR-BI) plays a critical role in the classic hepat
Autor:
Kanwardeep S. Bura, J. Mark Brown, Kathryn Kelley, Jun Zhang, Lawrence L. Rudel, Martha D. Wilson, Manya Warrier
Statin drugs have proven a successful and relatively safe therapy for the treatment of atherosclerotic cardiovascular disease (CVD). However, even with the substantial low-density lipoprotein (LDL) cholesterol lowering achieved with statin treatment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140fc2e8d038a7ee81e4f0040b7c416b
https://europepmc.org/articles/PMC5221701/
https://europepmc.org/articles/PMC5221701/
Publikováno v:
European Journal of Pain. 17:832-843
Background The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to
Autor:
R. Sánchez-Arroyos, Rafael Maldonado, M. Laloya, C. Segalés, Jesús Giraldo, E Hernández, Daniel Zamanillo, Ana Montero, A. S. Bura, Javier Burgueño, Carlos R. Plata-Salamán, Xavier Nadal, M Escriche, José M. Baeyens, Enrique Portillo-Salido, Luz Romero, Ivan Rivera-Arconada, Asunción Muro, Xavier Codony, J.A. Lopez-Garcia, José Miguel Vela, G Encina, Manuel Merlos, Alberto Dordal
Publikováno v:
British Journal of Pharmacology. 166:2289-2306
BACKGROUND AND PURPOSE The sigma-1 (σ(1) ) receptor is a ligand-regulated molecular chaperone that has been involved in pain, but there is limited understanding of the actions associated with its pharmacological modulation. Indeed, the selectivity a
Publikováno v:
European journal of pain (London, England). 17(6)
The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the
Autor:
Miquel Martin, Andreas Zimmer, Fatima Bosch, Maria Molas, Judith Agudo, Carles Roca, Rafael Maldonado, A. S. Bura
Publikováno v:
Diabetologia. 53(12)
The endocannabinoid system has a key role in energy storage and metabolic disorders. The endocannabinoid receptor 2 (CB2R), which was first detected in immune cells, is present in the main peripheral organs responsible for metabolic control. During o
Autor:
La Porta C; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain Department of Experimental and Health Sciences, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain Cell Research Group on Inflammation and Cartilage, Hospital del Mar Medical Research Institute, Rheumatology Department, Hospital del Mar, Barcelona, Spain Human Pharmacology and Clinical Neurosciences Research Group, Neuroscience Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Alicante, Spain CIBER de Fisiopatología Obesidad y Nutrición, Santiago de Compostela, Spain Department of Rheumatology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain (A. S. Bura is now with the Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, München, Germany)., Bura SA, Llorente-Onaindia J, Pastor A, Navarrete F, García-Gutiérrez MS, De la Torre R, Manzanares J, Monfort J, Maldonado R
Publikováno v:
Pain [Pain] 2015 Oct; Vol. 156 (10), pp. 2001-2012.